In preclinical studies, 5-Amino-1MQ has been shown to: Improve grip strength by up to 40% Increase muscle cross-sectional area Boost muscular endurance Activate muscle stem cells Reduce fat mass Protect against diet-induced obesity Theres even emerging evidence suggesting potential roles in: Cardiovascular disease Alzheimers disease Parkinsons disease Now, I do want to be clear about where the science stands
Any suggestion of use in performance enhancement, therapy, or self-administration would breach The Human Medicines Regulations 2012 and related UK legislation
12 mg in the common trial arm)
Sustained preclinical observations documented at 812 weeks
Testing may include: HPLC purity analysis LC-MS identity confirmation peptide mass review quantity testing impurity profiling batch documentation COA review For a modified peptide such as IGF-1 LR3, testing can help connect the product name to the material being supplied
showed that 500 M MnCl 2 exposure increased caspase 3 cleavage and reduced cell viability in PC12 cells (Yagyu et al., 2020)